Anti-SIGLEC7 / CD328 Antibody (aa19-357)
| Name | Anti-SIGLEC7 / CD328 Antibody (aa19-357) |
|---|---|
| Supplier | LifeSpan Bioscience |
| Catalog | LS-C150069 |
| Prices | $395.00 |
| Sizes | 100 µg |
| Host | Goat |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | IHC-F FC |
| Species Reactivities | Human |
| Antigen | SIGLEC7 / CD328 antibody was raised against mouse myeloma cell line NS0-derived recombinant human Siglec7/CD328 Gln19-Gly357 Accession # Q9Y286. |
| Purity/Format | Immunoaffinity purified |
| Description | Goat Polyclonal |
| Gene | SIGLEC7 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Cell Adhesion Mediated by Siglec-7 and Neutralization by Human Siglec-7 Antibody. Recombinant Human Siglec-7 Fc Chimera, immobilized onto a microplate, supports the adhesion of human red blood cells in a dose-dependent manner (orange line). Adhesion elicited by Recombinant Human Siglec-7 Fc Chimera (5 ug/ml) is neutralized (green line) by increasing concentrations of Goat Anti-Human Siglec-7 Antigen Affinity-purified Polyclonal Antibody. The ND50 is typically 0.3-0.9 ug/ml.